Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mod Rheumatol
Hlavní autoři: Tanaka, Yoshiya, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Sumida, Takayuki, Mimori, Tsuneyo, Koike, Takao, Endo, Kazuhiro, Mashino, Naomi, Yamamoto, Kazuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://ncbi.nlm.nih.gov/pubmed/26054418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1060665
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky